Antiviral Res
- ZHANG X, Xia Y, Li P, Wu Z, et al
Discovery of cyperenoic acid as a potent and novel entry inhibitor of influenza A
virus.
Antiviral Res. 2024 Feb 11:105822. doi: 10.1016/j.antiviral.2024.105822.
- IZMAILYAN R, Matevosyan M, Khachatryan H, Shavina A, et al
Discovery of new antiviral agents through artificial intelligence: In vitro and
in vivo results.
Antiviral Res. 2024;222:105818.
- BOUZIDI HS, Driouich JS, Klitting R, Bernadin O, et al
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.
Antiviral Res. 2024 Jan 23:105814. doi: 10.1016/j.antiviral.2024.105814.
- IDRIS A, Supramaniam A, Tayyar Y, Kelly G, et al
An intranasally delivered ultra-conserved siRNA prophylactically represses
SARS-CoV-2 infection in the lung and nasal cavity.
Antiviral Res. 2024;222:105815.
- RICHTER M, Doring K, Blaas D, Riabova O, et al
Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine
capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket:
Derivatives that brake resistance.
Antiviral Res. 2024;222:105810.
- GOVEDNIK T, Lainscek D, Kuhar U, Lachish M, et al
TXM peptides inhibit SARS-CoV-2 infection, syncytia formation, and lower
inflammatory consequences.
Antiviral Res. 2024 Jan 9:105806. doi: 10.1016/j.antiviral.2024.105806.
- LOAIZA RA, Ramirez RA, Sepulveda-Alfaro J, Ramirez MA, et al
A molecular perspective for the development of antibodies against the human
respiratory syncytial virus.
Antiviral Res. 2024;222:105783.
BMJ
- MCGREGOR G, Sandhu H, Bruce J, Sheehan B, et al
Clinical effectiveness of an online supervised group physical and mental health
rehabilitation programme for adults with post-covid-19 condition (REGAIN study):
multicentre randomised controlled trial.
BMJ. 2024;384:e076506.
- HINMAN RS, Maher CG
Rehabilitation for post-covid-19 condition.
BMJ. 2024;384:q20.
- IACOBUCCI G
Long covid: Online rehabilitation can improve quality of life, study reports.
BMJ. 2024;384:q346.
-
Seven days in medicine: 31 Jan to 6 Feb 2024.
BMJ. 2024;384:q299.
- CIPRIANO CB, Kadakia KT, Chokshi DA
Is the US prepared for the next pandemic? No, but it could be.
BMJ. 2024;384:q332.
Epidemiol Infect
- YAMAYOSHI S, Nagai E, Mitamura K, Hagihara M, et al
Seroprevalence of severe acute respiratory syndrome coronavirus 2 N antibodies
between December 2021 and march 2023 in Japan.
Epidemiol Infect. 2024;152:e24.
J Clin Microbiol
- DURANT TJS, Peaper DR
Retrospective evaluation of clinical decision support for within-laboratory
optimization of SARS-CoV-2 NAAT workflow.
J Clin Microbiol. 2024;62:e0078523.
- PFAU B, Opsahl J, Crew R, Best S, et al
Tiny swabs: nasal swabs integrated into tube caps facilitate large-scale
self-collected SARS-CoV-2 testing.
J Clin Microbiol. 2024;62:e0128523.
J Infect Dis
- AMINISANI N, Wood T, Jelley L, Wong C, et al
The burden of HMPV and influenza associated hospitalizations in adults in New
Zealand, 2012-2015.
J Infect Dis. 2024 Feb 13:jiae064. doi: 10.1093.
J Virol
- NIE L, Huang Y, Cheng Z, Luo H, et al
An intranasal influenza virus vector vaccine protects against Helicobacter pylori
in mice.
J Virol. 2024 Feb 15:e0192323. doi: 10.1128/jvi.01923.
- ZENG J, Du F, Xiao L, Sun H, et al
Spatiotemporal genotype replacement of H5N8 avian influenza viruses contributed
to H5N1 emergence in 2021/2022 panzootic.
J Virol. 2024 Feb 15:e0140123. doi: 10.1128/jvi.01401.
- THOMAS MN, Zanella GC, Cowan B, Caceres CJ, et al
Nucleoprotein reassortment enhanced transmissibility of H3 1990.4.a clade
influenza A virus in swine.
J Virol. 2024 Feb 14:e0170323. doi: 10.1128/jvi.01703.
- KATAYAMA M, Murakami S, Ishida H, Matsugo H, et al
Antigenic commonality and divergence of hemagglutinin-esterase-fusion protein
among influenza D virus lineages revealed using epitope mapping.
J Virol. 2024 Feb 12:e0190823. doi: 10.1128/jvi.01908.
JAMA
- RAGLOW Z, Malani PN, Petty LA
Outpatient Treatment for COVID-19.
JAMA. 2023 Aug 16. doi: 10.1001/jama.2023.16666.
Lancet
- DELFRAISSY JF, Horgan M, Molbak K, Simon FS, et al
Scientific advisory councils in the COVID-19 response.
Lancet. 2023 Oct 12:S0140-6736(23)01846-9. doi: 10.1016/S0140-6736(23)01846.
-
Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort
studies in England, Northern Ireland, Scotland, and Wales.
Lancet. 2024 Jan 12:S0140-6736(23)02467-4. doi: 10.1016/S0140-6736(23)02467.
- GULLIFORD MC, Steves CJ
Access to COVID-19 vaccination and COVID-19-related hospital admissions and
mortality.
Lancet. 2024 Jan 12:S0140-6736(23)02622-3. doi: 10.1016/S0140-6736(23)02622.
- ADERINTO N, Olatunji G, Kokori E
Health implications of GSK's departure from Nigeria.
Lancet. 2024;403:526-527.
PLoS Comput Biol
- VAN BOVEN M, van Dorp CH, Westerhof I, Jaddoe V, et al
Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective
household study.
PLoS Comput Biol. 2024;20:e1011832.
- CHAN LYH, Ro G, Midtbo JE, Di Ruscio F, et al
Modeling geographic vaccination strategies for COVID-19 in Norway.
PLoS Comput Biol. 2024;20:e1011426.
PLoS One
- LAOR T
Public and commercial more of the same? The characteristics of the opening
monologues of public and commercial channels during the COVID-19 pandemic.
PLoS One. 2024;19:e0293172.
- GONG Z, Wang Y, Li M
Determining the drivers of global innovation under COVID-19: An FSQCA approach.
PLoS One. 2024;19:e0295403.
- ROSENBERG A, Puglisi LB, Thomas KA, Halberstam AA, et al
"It's just us sitting there for 23 hours like we done something wrong":
Isolation, incarceration, and the COVID-19 pandemic.
PLoS One. 2024;19:e0297518.
- MCCABE EM, Luk JW, Stangl BL, Schwandt ML, et al
Exercising healthy behaviors: A latent class analysis of positive coping during
the COVID-19 pandemic and associations with alcohol-related and mental health
outcomes.
PLoS One. 2024;19:e0297060.
- BOSTAN ALI W, Olayinka JA, Alam MM, Immelman A, et al
Assessing economic implications for micro, small and medium enterprises in
Thailand post Covid-19 lockdown.
PLoS One. 2024;19:e0294890.
- GORGELS KMF, van Iersel SCJL, Keijser SFA, Hoebe CJPA, et al
Estimating infection prevalence using the positive predictive value of
self-administered rapid antigen diagnostic tests: An exploration of SARS-CoV-2
surveillance data in the Netherlands from May 2021 to April 2022.
PLoS One. 2024;19:e0298218.
- SHIROSHITA A, Gebretsadik T, Wu P, Kubilay NZ, et al
Association between age of respiratory syncytial virus infection hospitalization
and childhood asthma: A systematic review.
PLoS One. 2024;19:e0296685.
- MORENO-JUSTE A, Poblador-Plou B, Ortega-Larrode C, Laguna-Berna C, et al
Mental health and risk of death and hospitalization in COVID-19 patients. Results
from a large-scale population-based study in Spain.
PLoS One. 2024;19:e0298195.
- CHEN TL, Chou EP, Chen MY, Hsieh F, et al
Unraveling implicit human behavioral effects on dynamic characteristics of
Covid-19 daily infection rates in Taiwan.
PLoS One. 2024;19:e0298049.
- CILDOZ M, Gaston M, Frias L, Garcia-Vicuna D, et al
Early detection of new pandemic waves. Control chart and a new surveillance
index.
PLoS One. 2024;19:e0295242.
- ASAMOAH I, Adusei-Poku M, Vandyck-Sey P, Steele-Dadzie A, et al
COVID-19 in patients presenting with malaria-like symptoms at a primary
healthcare facility in Accra, Ghana.
PLoS One. 2024;19:e0298088.
- VAN DUSEN J, LeBlanc H, Nastasi N, Panescu J, et al
Identification of SARS-CoV-2 variants in indoor dust.
PLoS One. 2024;19:e0297172.
- GUADALUPE-FERNANDEZ V, Martinez-Solanas E, Sabria-Sunye A, Ferrer-Mikoly C, et al
Investigating epidemiological distribution (temporality and intensity) of
respiratory pathogens following COVID-19 de-escalation process in Catalonia,
September 2016-June 2021: Analysis of regional surveillance data.
PLoS One. 2024;19:e0285892.
- VEPACHEDU S, Nurzenska A, Lohiniva AL, Hudi AH, et al
Understanding COVID-19 vaccination behaviors and intentions in Ghana: A
Behavioral Insights (BI) study.
PLoS One. 2024;19:e0292532.
- GALUSHKO V, Riabchyk A
The demand for online grocery shopping: COVID-induced changes in grocery shopping
behavior of Canadian consumers.
PLoS One. 2024;19:e0295538.
- MOLONEY K, Lamprea Montealegre JA, Busch Isaksen TM, Kennedy M, et al
Assessing community-level impacts of and responses to stay at home orders: The
King County COVID-19 community study.
PLoS One. 2024;19:e0296851.
- SIM J, Shin J, Lee HJ, Lee Y, et al
Impact of coronavirus disease 2019 on cancer care: How the pandemic has changed
cancer utilization and expenditures.
PLoS One. 2024;19:e0296808.
- ASADI-POOYA AA, Nemati M, Shahisavandi M, Nemati H, et al
How does COVID-19 vaccination affect long-COVID symptoms?
PLoS One. 2024;19:e0296680.
- CHAPUT J, Becquet V, Bithorel PL, Baril E, et al
Medication abortion during the COVID-19 pandemic in France: A research based on
the French national health insurance database.
PLoS One. 2024;19:e0295336.
- LI L, Sullivan A, Musah A, Stavrianaki K, et al
Positive and negative emotions during the COVID-19 pandemic: A longitudinal
survey study of the UK population.
PLoS One. 2024;19:e0297214.
- RIUS-SALVADOR M, Garcia-Murria MJ, Rusu L, Bano-Polo M, et al
Cetylpyridinium chloride and chlorhexidine show antiviral activity against
Influenza A virus and Respiratory Syncytial virus in vitro.
PLoS One. 2024;19:e0297291.
Vaccine
- OKOLI GN, Righolt CH, Zhang G, Van Caeseele P, et al
A population-based, province-wide, record-linkage interrupted time series
analysis of impact of the universal seasonal influenza vaccination policy on
seasonal influenza vaccine uptake among 5-64-year-olds in the province of
Manitoba, Canada.
Vaccine. 2024 Feb 14:S0264-410X(24)00104-X. doi: 10.1016/j.vaccine.2024.
- AMDISEN L, Pedersen L, Abildgaard N, Benn CS, et al
The coverage of influenza vaccination and predictors of influenza non-vaccination
in Danish cancer patients: A nationwide register-based cohort study.
Vaccine. 2024 Feb 12:S0264-410X(24)00155-5. doi: 10.1016/j.vaccine.2024.
- VALENTIN J, Ingrao F, Rauw F, Lambrecht B, et al
Protection conferred by an H5 DNA vaccine against highly pathogenic avian
influenza in chickens: The effect of vaccination schedules.
Vaccine. 2024 Feb 12:S0264-410X(23)01422-6. doi: 10.1016/j.vaccine.2023.
- WHITAKER HJ, Hassell K, Hoschler K, Power L, et al
Influenza vaccination during the 2021/22 season: A data-linkage test-negative
case-control study of effectiveness against influenza requiring emergency care in
England and serological analysis of primary care patients.
Vaccine. 2024 Feb 10:S0264-410X(24)00150-6. doi: 10.1016/j.vaccine.2024.
- WEI J, Tan TC, Moa AM, MacIntyre CR, et al
Cost-benefit of influenza vaccination in preventing sudden cardiac arrest amongst
Australian adults.
Vaccine. 2024 Feb 9:S0264-410X(24)00154-3. doi: 10.1016/j.vaccine.2024.
- GRIMA AA, Kwong JC, Richard L, Reid J, et al
The safety of seasonal influenza vaccination among adults prescribed immune
checkpoint inhibitors: A self-controlled case series study using administrative
data.
Vaccine. 2024 Jan 17:S0264-410X(24)00023-9. doi: 10.1016/j.vaccine.2024.
- GEINITZ H, Silberberger E, Spiegl K, Feichtinger J, et al
SARS-CoV-2 vaccination willingness and humoral vaccination response in radiation
oncology patients.
Vaccine. 2024 Jan 20:S0264-410X(24)00004-5. doi: 10.1016/j.vaccine.2024.
- MITCHELL MM, Klott A, Scholtes J, Braden BB, et al
Mixed-methods examination of attitudes and behaviors related to COVID-19 vaccines
among parents of children with autism and autistic adults.
Vaccine. 2024 Jan 19:S0264-410X(24)00013-6. doi: 10.1016/j.vaccine.2024.
- HICKEN A, Jones P, Menon A, Rozek LS, et al
Can endorsement by religious leaders move the needle on vaccine hesitancy?
Vaccine. 2024 Jan 18:S0264-410X(24)00006-9. doi: 10.1016/j.vaccine.2024.
- MEMEDOVICH A, Orr T, Hollis A, Salmon C, et al
Social network risk factors and COVID-19 vaccination: A cross-sectional survey
study.
Vaccine. 2024 Jan 18:S0264-410X(24)00005-7. doi: 10.1016/j.vaccine.2024.
- LEMMER Y, Chapman R, Abolnik C, Smith T, et al
Protective efficacy of a plant-produced beta variant rSARS-CoV-2 VLP vaccine in
golden Syrian hamsters.
Vaccine. 2024 Jan 17:S0264-410X(24)00036-7. doi: 10.1016/j.vaccine.2024.
- HARALAMBIEVA IH, Monroe JM, Ovsyannikova IG, Warner ND, et al
Restricted Omicron-specific cross-variant memory B-cell immunity after a 3rd
dose/booster of monovalent Wuhan-Hu-1-containing COVID-19 mRNA vaccine.
Vaccine. 2024 Jan 16:S0264-410X(24)00032-X. doi: 10.1016/j.vaccine.2024.
- MCADAM E, Hayashi K, Barker B, Reddon H, et al
COVID-19 vaccination among young people who use drugs in Vancouver, Canada.
Vaccine. 2024 Jan 14:S0264-410X(24)00009-4. doi: 10.1016/j.vaccine.2024.
- RANDELL M, Sheel M, Dynes M, Li M, et al
Influence of the COVID-19 pandemic on caregiver beliefs and experiences of
routine childhood immunisation in Indonesia.
Vaccine. 2024;42:812-818.
- QURESHI NS, Miller LG, Judge SP, Tran NDT, et al
Characterizing predictors of COVID-19 vaccine refusal in an urban southern
California jail population.
Vaccine. 2024 Jan 9:S0264-410X(24)00017-3. doi: 10.1016/j.vaccine.2024.
- BARZEN G, Rieber F, Stangl K, Hahn K, et al
mRNA vaccines for COVID-19 are safe and clinically effective in patients with
cardiac amyloidosis.
Vaccine. 2023 Dec 28:S0264-410X(23)01487-1. doi: 10.1016/j.vaccine.2023.
- CENAT JM, Moshirian Farahi SMM, Broussard C, Dalexis RD, et al
The state of COVID-19 vaccine confidence and need in Black individuals in Canada:
Understanding the role of sociodemographic factors, health literacy, conspiracy
theories, traumatic stressors and racial discrimination.
Vaccine. 2023 Oct 25:S0264-410X(23)01246-X. doi: 10.1016/j.vaccine.2023.
Virus Res
- WANG X, Cheng J, Shen L, Chen M, et al
Rab5c promotes RSV and ADV replication by autophagy in respiratory epithelial
cells.
Virus Res. 2024;341:199324.
- HUANG X, Kantonen J, Nowlan K, Nguyen NA, et al
Mucosal-Associated Invariant T Cells are not susceptible in vitro to SARS-CoV-2
infection but accumulate into the lungs of COVID-19 patients.
Virus Res. 2024;341:199315.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016